orthoPACE™ (Prod 10513)

About orthoPACE™ (Prod 10513)

The orthoPACE™ incorporates the Company's proprietary Pulsed Acoustic Cellular Expression (PACE) technology platform that delivers extracorporeal shock wave technology (ESWT) to treat a wide variety of chronic and acute conditions in hard and soft tissue.

This award-winning device platform generates high energy, electrohydraulic shock waves that activate biological signaling and angiogenic responses, including revascularization and microcirculatory improvement, helping restore the body's normal healing processes and promote regeneration.

The orthoPACE™ has a compact, portable design and allows for treatments to be performed by a single operator in both the hospital and office setting.

The device features a new, unique applicator that is less painful for some indications and may reduce or completely eliminate anesthesia for some patients.

The product, which replaces the Ossatron device, will be used for tendinoplasties and acute and non-union fractures.

Request Product Information







OrthopaedicLIST.com is a list of products and services. Every effort is made to keep this listing as accurate and current as possible. Companies and individuals are encouraged to notify us of errors and omissions. We will respond to such messages of correction in a timely fashion, as our workload permits.

We are non-judgmental of products listed. We are not in the business of evaluating products. We have not evaluated these products. We make no representations as to the quality, effectiveness, suitability or appropriateness of any of the products listed.

As an important component of the service function of OrthopaedicLIST.com, some products continue to be listed that are no longer manufactured and may not be available. We will identify them as such when possible. This allows users to find special instruments and/or components for removal, modification, and/or revision of those products.